7-day fecal molecular susceptibility-guided therapy

DRUG2 trials

Sponsors

Shanghai Zhongshan Hospital

Conditions

HELICOBACTER PYLORI INFECTIONSHelicobacter Pylori Infection

Phase 4

Fecal Molecular Susceptibility-guided Hp First-line Therapy

Not yet recruitingNCT07405684

Shanghai Zhongshan HospitalHELICOBACTER PYLORI INFECTIONS

Start: 2026-02-28End: 2028-12-31Target: 544Updated: 2026-02-12

Fecal Molecular Susceptibility-guided Hp Rescue Therapy

Not yet recruitingNCT07405697

Shanghai Zhongshan HospitalHelicobacter Pylori Infection

Start: 2026-02-28End: 2028-12-31Target: 290Updated: 2026-02-12